Medical Devices

OCR 6362

The first percutaneously delivered fully implantable heart assist device with long-term LVAD function.

OCR 5199

Yale researchers have identified that the acute inflammatory response to biomaterials can be limited by inhibition of inflammasome-related pathways.

OCR 5121

Yale University investigators have developed a new MR imaging method that accelerates image acquisition beyond conventional and parallel imaging methods. Rather than using linear encoding gradients as employed by current parallel imaging methods, O-space imaging utilizes nonlinear fields as encoding gradients and eliminates phase encoding. Since the spatial encoding gradient shapes are tailored to an existing surface coil array, more efficient use is made of the spatial information in the coil profiles. As an added benefit, nonlinear gradients may be ramped faster than linear gradients, further reducing image acquisition times.

OCR 1674

A collaborative research effort, performed in part with Yale, has identified a unique method to induce the formation of new bone in targeted skeletal sites, as well as accelerate and secure the repair process of fractures.

OCR 4169

A surgical table includes a horizontal patient support with a base extending therefrom and supporting the patient support at a desired height. The surgical table also includes an adjustment platform positioned upon the patient support. The adjustment platform includes a plurality of expansion members adapted to selectively adjust the relative position of the patient.

OCR 4444

The present invention relates to the risk assessment, detection, diagnosis, or prognosis of prostate cancer. More specifically, this invention relates to the detection of certain polymorphism in the promoter region of the MIF gene to determine the risk, detect, diagnose, or prognosticate prostate cancer. Applicants have discovered that the presence of a -173C and/or -749 (CATT).sub.7 or more repeat predispose an individual to prostate cancer.

OCR 4832

Methods for increasing the patency of biodegradable, synthetic vascular grafts are provided. The methods include administering one or more cytokines and/or chemokines that promote outward tissue remodeling of the vascular grafts and vascular neotissue formation. The disclosed methods do not require cell seeding of the vascular grafts, thus avoiding many problems associated with cell seeding. Biodegradable, polymeric vascular grafts which provide controlled release of cytokines and/or chemokines at the site of vascular graft implantation are also provided.